Marketing-authorisation holder · Denmark
XGX Pharma ApS
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Carblit 300 mg tablettenTablet | Lithium | Netherlands | Authorised | 2026 |
| Deflazacort XGX Pharma 30 mg tablettenTablet | Deflazacort | Netherlands | Authorised | 2021 |
| Deflazacort XGX Pharma 6 mg tablettenTablet | Deflazacort | Netherlands | Authorised | 2021 |
| Kacital 1080 mg, tabletten met gereguleerde afgifteTablet met gereguleerde afgifte | Potassium citrate | Netherlands | Authorised | 2024 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 4 | 4 | 0 | CompaniesAll medicines |